Atualizações recentes
  • The soft tissue sarcoma market is projected to be worth over USD 420 million in 2030, growing at an annualized rate of 27.54% during the period 2021-2030, claims Roots Analysis

    Recent advances in molecular biology have enabled researchers to develop a better understanding of the rare soft tissue sarcomas; as a result, a number of viable biological targets have been identified and are being investigated for therapeutic relevance.

    For additional details, please visit https://www.rootsanalysis.com/reports/soft-tissue-sarcoma-market.html
    The soft tissue sarcoma market is projected to be worth over USD 420 million in 2030, growing at an annualized rate of 27.54% during the period 2021-2030, claims Roots Analysis Recent advances in molecular biology have enabled researchers to develop a better understanding of the rare soft tissue sarcomas; as a result, a number of viable biological targets have been identified and are being investigated for therapeutic relevance. For additional details, please visit https://www.rootsanalysis.com/reports/soft-tissue-sarcoma-market.html
    Roots Analysis
    Soft Tissue Sarcoma Market report features an extensive study of the current landscape and the likely future potential of single-use system...
    0 Comentários 0 Compartilhamentos
  • The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030, predicts Roots Analysis

    Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals.

    For additional details, please visit
    https://www.rootsanalysis.com/reports/view_document/subcutaneous-biologics-delivery/314.html
    The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030, predicts Roots Analysis Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/subcutaneous-biologics-delivery/314.html
    WWW.ROOTSANALYSIS.COM
    Subcutaneous Biologics Formulation Technologies and Drug Delivery Systems (4th Edition) Market | Industry Analysis | Market Size | 2030
    Market research report on subcutaneous biologics, technologies and drug delivery systems with focus on current market landscape and 2035 market size of...
    0 Comentários 0 Compartilhamentos
  • The synthetic lethality-based drugs and targets market is estimated to be worth USD 8 billion in 2030, predicts Roots Analysis

    Advances in molecular screening technology have enabled the identification of novel synthetic lethal gene combinations, enabling the development of lead candidates that leverage the aforementioned phenomenon to offer therapeutic benefit.

    For more information please click on the following link:
    https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-dna-repair-including-parp-inhibitors-and-other-novel-cellular-pathways/267.html
    The synthetic lethality-based drugs and targets market is estimated to be worth USD 8 billion in 2030, predicts Roots Analysis Advances in molecular screening technology have enabled the identification of novel synthetic lethal gene combinations, enabling the development of lead candidates that leverage the aforementioned phenomenon to offer therapeutic benefit. For more information please click on the following link: https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-dna-repair-including-parp-inhibitors-and-other-novel-cellular-pathways/267.html
    WWW.ROOTSANALYSIS.COM
    Synthetic Lethality-based Drugs: Focus on DNA Repair (PARP Inhibitors) | Industry Analysis | Market Size | 2030
    Synthetic Lethality-based Drugs (DNA repair, parp inhibitors, brca gene mutation, pi3k inhibitor and others) Market is Poised to Witness a Rapid Growth
    0 Comentários 0 Compartilhamentos
  • The targeted protein degradation enabling technologies market, featuring a healthy pipeline of novel therapeutics, is anticipated to be worth over USD 3.3 billion by 2030, predicts Roots Analysis

    Targeted protein degradation has emerged as a revolutionary pharmacological concept that presents both viable and versatile drug development opportunities and is anticipated to introduce a new paradigm in modern healthcare.

    For additional details, please visit
    https://www.rootsanalysis.com/reports/view_document/protein-degradation-market/289.html
    The targeted protein degradation enabling technologies market, featuring a healthy pipeline of novel therapeutics, is anticipated to be worth over USD 3.3 billion by 2030, predicts Roots Analysis Targeted protein degradation has emerged as a revolutionary pharmacological concept that presents both viable and versatile drug development opportunities and is anticipated to introduce a new paradigm in modern healthcare. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/protein-degradation-market/289.html
    WWW.ROOTSANALYSIS.COM
    Targeted Protein Degradation Market | Industry Analysis | Market Size | 2030
    Research report on the future opportunity of targeted protein degradation therapeutics and technology platforms
    0 Comentários 0 Compartilhamentos
  • In silico drug discovery services market is likely to be worth USD 124 million by 2030, growing at an annualized rate of 15.6%, claims Roots Analysis

    Owing to their cost and time saving potential, in silico tools are widely used in modern pharmacological research; several companies have developed novel tools, which are specifically designed to accelerate and augment the drug discovery process.

    For additional details, please visit
    https://www.rootsanalysis.com/reports/view_document/in-silico-drug-discovery/298.html
    In silico drug discovery services market is likely to be worth USD 124 million by 2030, growing at an annualized rate of 15.6%, claims Roots Analysis Owing to their cost and time saving potential, in silico tools are widely used in modern pharmacological research; several companies have developed novel tools, which are specifically designed to accelerate and augment the drug discovery process. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/in-silico-drug-discovery/298.html
    WWW.ROOTSANALYSIS.COM
    In Silico Drug Discovery Services: Focus on Biologics, SBDD, FBDD | Industry Analysis | Market Size | 2030
    In Silico tools / techniques are estimated to save as much as 35% of the conventional drug discovery process cost, enabling researchers to expedite the process
    0 Comentários 0 Compartilhamentos
  • In vitro ADME testing services market is likely to be worth USD 2.2 billion by 2030, growing at an annualized rate of ~9.8%, predicts Roots Analysis

    With increasing cases of drug failure, due to problems associated with pharmacokinetic profiles of candidate therapies, absorption, distribution, metabolism and excretion (ADME) properties and inherent toxicity, industry players are actively looking for more advanced solutions.

    For additional details, please visit
    https://www.rootsanalysis.com/reports/view_document/in-vitro-adme-testing-services-market-2019-2030/239.html

    In vitro ADME testing services market is likely to be worth USD 2.2 billion by 2030, growing at an annualized rate of ~9.8%, predicts Roots Analysis With increasing cases of drug failure, due to problems associated with pharmacokinetic profiles of candidate therapies, absorption, distribution, metabolism and excretion (ADME) properties and inherent toxicity, industry players are actively looking for more advanced solutions. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/in-vitro-adme-testing-services-market-2019-2030/239.html
    WWW.ROOTSANALYSIS.COM
    In Vitro ADME Testing Services Market | Industry Analysis | Market Size | 2030
    Within Asia-Pacific, markets in China and Japan are expected to grow at a relatively faster rate (~11%) in the coming decade.
    0 Comentários 0 Compartilhamentos
  • The human factors engineering and usability testing services market for medical devices is projected to reach USD 1 Billion by 2030, claims Roots Analysis

    Human factors engineering and usability testing have now become an essential part of product design across almost all industries, offering developers the chance to optimize proprietary products in alignment to the preferences of consumers.

    For additional details, please visit
    https://www.rootsanalysis.com/reports/human-factors-engineering-and-usability-testing-services.html
    The human factors engineering and usability testing services market for medical devices is projected to reach USD 1 Billion by 2030, claims Roots Analysis Human factors engineering and usability testing have now become an essential part of product design across almost all industries, offering developers the chance to optimize proprietary products in alignment to the preferences of consumers. For additional details, please visit https://www.rootsanalysis.com/reports/human-factors-engineering-and-usability-testing-services.html
    WWW.ROOTSANALYSIS.COM
    Human Factors Engineering & Usability Testing Services Market for Medical Devices | Market Size | 2030
    Market research report on human factors engineering & usability testing services for medical devices; focus on current market landscape & future opportunities
    0 Comentários 0 Compartilhamentos
  • Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030, growing at an annualized rate of over 40%, claims Roots Analysis

    Over the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic products, which may cause a paradigm shift in the way healthcare is delivered in the foreseen future.

    For additional details, please visit
    https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html
    Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030, growing at an annualized rate of over 40%, claims Roots Analysis Over the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic products, which may cause a paradigm shift in the way healthcare is delivered in the foreseen future. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html
    WWW.ROOTSANALYSIS.COM
    The Human Microbiome Market | Market Size | Industry Analysis | 2035
    The human microbiome report features an informed opinion on the likely adoption of microbiome-based therapeutics, diagnostics and FMTs, in...
    0 Comentários 0 Compartilhamentos
  • The intranasal therapeutics and drug delivery systems market is projected to grow at a CAGR of 18%, claims Roots Analysis

    Upon realizing the potential of this route of administration, industry stakeholders have initiated several R&D efforts focused on exploiting the use of intranasal therapeutics as an effective modality for the treatment of various disorders.
    For additional details, please visit
    https://www.rootsanalysis.com/reports/intranasal-therapeutics-and-drug-delivery-systems.html
    The intranasal therapeutics and drug delivery systems market is projected to grow at a CAGR of 18%, claims Roots Analysis Upon realizing the potential of this route of administration, industry stakeholders have initiated several R&D efforts focused on exploiting the use of intranasal therapeutics as an effective modality for the treatment of various disorders. For additional details, please visit https://www.rootsanalysis.com/reports/intranasal-therapeutics-and-drug-delivery-systems.html
    WWW.ROOTSANALYSIS.COM
    Intranasal Therapeutics and Drug Delivery Systems | Industry Analysis | Market Size | 2035
    Intranasal Therapeutics and Drug Delivery Systems; with a focus on current market landscape and future growth opportunities
    0 Comentários 0 Compartilhamentos
  • The gene-editing beyond CRISPR market is anticipated to grow at an annualized rate of 18%, claims Roots Analysis

    With the approval of HUMULIN®, the first genetically modified drug, scientific community has made significant progress in developing gene edited therapies based on programmable nucleases, such as ZFNs, TALENs, EMNs and CRISPR.

    For additional details, please visit
    https://www.rootsanalysis.com/reports/gene-editing-market.html
    The gene-editing beyond CRISPR market is anticipated to grow at an annualized rate of 18%, claims Roots Analysis With the approval of HUMULIN®, the first genetically modified drug, scientific community has made significant progress in developing gene edited therapies based on programmable nucleases, such as ZFNs, TALENs, EMNs and CRISPR. For additional details, please visit https://www.rootsanalysis.com/reports/gene-editing-market.html
    WWW.ROOTSANALYSIS.COM
    Gene Editing beyond CRISPR Market | Industry Analysis | Market Size | 2030
    Gene Editing beyond CRISPR Market report features an extensive study of the current market...
    0 Comentários 0 Compartilhamentos
Mais stories